Volume 23: Issue 4 (Oct 2024): Chronic Kidney Disease

in Nephrology Self-Assessment Program
Guest Editors: Adeera Levin, MD; Paul E. Stevens, MD
Editorial Director: Alice M. Sheridan, MD, FASN
Deputy Editor: Martina M. McGrath, MBChB, FASN 

 

AMA PRA Category 1 Credits™ Available
For more information regarding CME for this issue, access the CME tab below

CE Credit Termination Date: September 30, 2026

Looking for the Full Issue PDF Download?
Scroll to the bottom of the page and select "Download the Full Issue"

earphone iconListen to the Editorial Podcast
New Series: nephSAP Guest Editor Interview: CKD Coming of Age  (.mp3)
Released: 10/29/2024 | Duration: 00:27:15  | File Size: 18.20 MB

Learning Objectives

  • To analyze the prevalence of CKD across time and comprehend its global magnitude and health care burden.
  • To discuss the controversies in the definition of CKD and review the current recommendations to obtain an eGFR.
  • To review the main risk factors and how they impact the development of CKD.
  • To describe the factors implicated in the progression of CKD.

It is the policy of the American Society of Nephrology (ASN) that all individuals in a position to control the content of ASN's educational activities are expected to disclose all their and their life spouse/partner's financial relationships with “ineligible companies” within the prior 24 months as well as other non-financial interests. (“Ineligible companies” are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients.) Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in educational activities, but rather to ensure that these activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

ASN requires all individuals in a position to control content for this activity to complete disclosure forms on the ASN website. Responses are listed below.

Disclosures have been reviewed and assessed by ASN. All relationships with ineligible companies have been identified and all relevant financial relationships have been mitigated.

View the full ASN Conflict of Interest and Disclosure Policy: https://www.asn-online.org/education/cme/coi-disclosure.pdf.

EDITORS:

Alice M. Sheridan, MD, FASNEmployer(s): Brigham and Women’s Hospital; No additional relevant financial relationship(s) with ineligible companies to disclose.

Martina M. McGrath, MBChB, FASNEmployer(s): Brigham and Women’s Hospital; VA Boston Medical Center; Honoraria: Lexicon Pharmaceuticals.

EDITORIAL AUTHORS:

Paul E. Stevens, MDEmployer(s): East Kent Hospitals University NHS Foundation Trust; Advisory or Leadership Role: Member & Treasurer- KDIGO executive committee, Co-Chair- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD, Chair- South East Clinical Senate NHS England, Chair- South East London Kent and Medway Trauma Network.

Adeera Levin, MDEmployer(s): University of British Columbia; BC Provincial Renal Agency; Providence health Care; Consultancy: NIH; Chinook Therapeutics; REATA; Bayer; GSK, Boeingher Ingleheim; Astra Zeneca, Kidney Foundation of Canada, Janssen, Otsuka, Occuryx/Certa, Novo Nordisk; Research Funding: Canadian Institute of Health Research (CIHR), Kidney Foundation of Canada, Boehringer Ingelheim, Astra Zeneca, GSK, CITF (Canadian Immunology Task Force), Health Research BC, MOH BC, Shared Care BC; Honoraria: NIH; Janssen, AstraZeneca, Bayer, GSK; Advisor or Leadership Role: Boehringer Ingelheim, AstraZeneca, and NIDDK, DSMB for NIDDK, Kidney Precision Medicine, U Washington Kidney Research Institute Scientific Advisory Committee, International Society of Nephrology Research Committee, KRESCENT (Kidney Scientist Education Research National Training Program), GSK, Chinook Therapeutics, BC Renal (Exec Director), Steering Committee Chair CURE Consortium, CADTH, CITF, Co Lead Long Covid Web Grant, PI CanSOLVE CKD.

AUTHORS:

Hector Alvarado Verduzco, MDEmployer(s): Columbia University Medical Center; No relevant financial relationship(s) with ineligible companies disclosed.

Farid Arman, MDEmployer(s): University of California; No relevant financial relationship(s) with ineligible companies disclosed.

David Cherney, MDCM, PhDEmployer(s): University Health Network, Toronto General Hospital Research Institute, University of Toronto; Consultancy: Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, Lexicon, BMS, Maze, CSL-Behring, Otsuka, Novartis, Yeungene and Novo-Nordisk; Research Funding: Boehringer Ingelheim-Lilly, Merck, Novo Nordisk and AstraZeneca, CSL-BEHRING; Honoraria: Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, BMS, Maze, CSL-Behring, Otsuka, Novartis, Yeungene and Novo-Nordisk; Advisory or Leadership Role: Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Lexicon, Janssen, Bayer, BMS, Maze, CSL-Behring, Novartis, Novo-Nordisk.

Daphne Harrington Knicely, MD, FASNEmployer(s): University of Virginia; No relevant financial relationship(s) with ineligible companies disclosed.

Ayodele Odutayo, MD, DPhilEmployer(s): University Health Network, Toronto General Hospital Research Institute and Sunnybrook Health Sciences Centre, University of Toronto; Research Funding: Personal Research Funding Disclosure; Boehringer Ingelheim (BI) - coauthor on a secondary analysis of the EMPA-Reg trial (The analysis was funded by BI but no funding was personally received or directed to my institution). I am also a subinvestigator on EMPACT MI, which is funded by BI.; Bayer -Subinvestigator on FINEARTS-HF.

Shayan Shirazian, MDEmployer(s): Columbia University Irving Medical Center; Consultancy: Cara pharma, Vifor pharma, WebMD; Speakers Bureau: Otsuka.

Sumeska Thavarajah, MDEmployer(s): Johns Hopkins University School of Medicine; Honoraria: I was section editor for Medscape series on kidney disease - CME program; kidney disease subject matter expert on 2 webinars for MD Briefcase; Advisory or Leadership Role: Medical Advisory Board- NKF of Maryland- immediate past chair, previous vice chair- Maryland Kidney Commission 2021-2022, now current chair; Speakers Bureau: Kidney Subject Matter Expert on 2 webinars run by MD Briefcase; Other Interests: NKF- National Board member, member of the national scientific advisory board; Local NKF chapter- medical advisory board and board of advisors.

ASN STAFF:

Suzanne P. Armstrong, MAEmployer(s): American Society of Nephrology; No relevant financial relationship(s) with ineligible companies to disclose.

Lisa Netha Xayavong, MAEmployer(s): American Society of Nephrology; No relevant financial relationship(s) with ineligible companies to disclose.

Commercial Support

There is no commercial support for this issue.

The nephSAP editorial team and the KSAP editorial board extend their sincere appreciation to the following reviewers. Their efforts and insights help improve the quality of these postgraduate education offerings. 

nephSAP Review Panel, Volume 23, Number 4, October 2024

  • Josephine Abraham, MD, MPH, FASN, University of Utah, United States
  • Olufemi A. Aduroja, MD, FASN, Hopewell Medical Center, PLLC ,United States
  • Taha Ayach, MD, FASN ,University of Kentucky, United States
  • Shweta Bansal, MD, MBBS, FASN ,University of Texas Health at San Antonio, United States
  • Steven M. Gorbatkin, MD, PhD, FASN ,Veterans Affairs, United States
  • Susan Grossman, MD, Staten Island Nephrology; Brooklyn VA, United States
  • Swapnil Hiremath, MD, MPH, FASN,University of Ottawa, Canada
  • Elizabeth A. Kendrick, MD, FASN,The University of California, Los Angeles, United States
  • Paul A. Kovach, MD, FASN, Columbus Nephrology, Inc., United States
  • Georges Nakhoul, MD, MEd, FASN ,Cleveland Clinic Foundation, United States
  • Robert Nee, MD, FASN, Walter Reed National Military Medical Center, United States
  • Sankar Narayan Niranjan, MD, FASN, Greater Hartford Nephrology, United States
  • Kevin P. O'Reilly, MD, FASN ,Columbus Nephrology, Inc., United States
  • Nirupama Ramkumar, MD, MPH, FASN ,University of Utah, United States
  • Rupam Ruchi, MD, FASN, University of Florida, United States
  • Gurmukteshwar Singh, MD, FASN, Geisinger Health ,United States
  • James Sondheimer, MD, Wayne State University ,United States
  • Ekamol Tantisattamo, MD, MPH, FASN, University of California, Irvine School of Medicine, United States
  • Ravi K. Thimmisetty, MD, FASN ,Renal Medicine Associates, United States
  • Ruth L. Wintz, MD, FASN, Kidney Associates,United States

Program Mission and Objectives

nephSAP® provides a learning vehicle for physicians, scientists, advanced practitioners, nurses, pharmacists, and other health professionals working and training in the field of nephrology to renew and refresh their clinical knowledge, diagnostic, and therapeutic skills. This enduring material provides learners challenging, clinically-oriented questions based on case vignettes, detailed learning objectives, a series of articles that review recent publications, and an editorial on an important and evolving topic. This combination of materials enables learners to rigorously assess their strengths and weaknesses in the broad domain of nephrology.

Target Audience

Physicians, scientists, advanced practitioners, nurses, pharmacists, and other health professionals working and training in the field of nephrology.

Accreditation Statements

Jointly Accredited Provider LogoIn support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement – Physicians: The American Society of Nephrology designates this internet activity (enduring material) for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to Joint Accreditation for the purpose of granting ABIM MOC credit. MOC points will be applied to only those ABIM candidates who have enrolled in the MOC program. It is your responsibility to complete the ABIM MOC enrollment process.

Original Release Date: October 2024

CME/MOC Termination Date: September 30, 2026 at 11:59 pm ET

Examination Available Online: On or before October 31, 2024

Estimated Time for Completion: 10 hours 

Self-Assessment Examination

  • Answers with explanations are provided with a passing score after the first and/or second attempt
  • This issue will be archived October 1, 2026, and answers with explanations will be posted on the ASN website

Method of Participation

  • Read the entire issue that is supplemented by original articles in the reference lists.
  • Complete the online self-assessment examination.
  • Each participant is allowed two attempts to pass the examination (75% correct) for CME and MOC.
  • Upon completion, review your score and incorrect answers and print your certificate.

Activity Evaluation, CE, and MOC

  • Go to ASN eLEARNING CENTER (education.asn-online.org)
  • Select MY ACTIVITIES from the left-hand navigation.
  • Select the corresponding issue.
  • Read all information on the Overview screen.
  • Follow the onscreen instructions to:
    • Complete the Exam (i.e., post test),
    • Complete the Evaluation,
    • Claim credit/MOC, and
    • IMPORTANT: select the credit type that corresponds with your designation, and
    • Print a Certificate

Your ASN Transcript is available on the ASN website:

  • Go to the ASN website and log in to your ASN Profile page
  • Select the CME/CE Transcript tab
  • View credits claimed or print a certificate with continuing education information for completed learning activities

 

Instructions to obtain American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Points

Each issue of nephSAP provides 10 MOC points. Respondents must meet the following criteria:

  • Be certified by ABIM in internal medicine and/or nephrology and enrolled in the ABIM–MOC program...
  • Enroll for MOC via the ABIM website (www.abim.org).
  • Enter your (ABIM) Candidate Number and Date of Birth prior to completing the examination.
  • Take the self-assessment examination within the timeframe specified in this issue of nephSAP.
  • Upon completion, click Claim Your MOC points, the MOC points submitted will match your CME credits claimed, check the Attestation Statement box and submit.
  • ABIM will notify you when MOC points have been added to your record.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to Joint Accreditation for the purpose of granting ABIM MOC credit.
 
MOC points will be applied to only those ABIM candidates who have enrolled in the MOC program. It is your responsibility to complete the ABIM MOC enrollment process.
 

System Requirements Compatible Browser and Software

The nephSAP website (nephsap.org) is formatted for cross-browser functionality, and should display correctly in all currently supported web browsers. Individual nephSAP articles are available as dynamic HTML or in Portable Document Format (PDF), which requires Adobe Reader or comparable PDF viewing software.
 

Monitor Settings

The nephSAP website is designed for responsive display. This means the content display will respond to the device you use and to your devices screen resolution.  
 

Medium or Combination of Media Used

The media used include content provided online as dynamic HTML or downloadable PDF, in addition to an online evaluation and self-assessment examination.
 

Technical Support

If you have difficulty viewing any of the pages, please refer to the nephSAP technical support page for possible solutions. If you continue having problems, contact ASN at nephsap@asn-online.org.
 

 

  • Collapse
  • Expand

Volume 23: Issue 4 (Oct 2024): Chronic Kidney Disease

in Nephrology Self-Assessment Program